Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease

NCT01068600 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01068600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01068600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
Not reported
Enrollment
318 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease